www.fdanews.com/articles/83853-genentech-stops-allergy-drug-trial
GENENTECH STOPS ALLERGY DRUG TRIAL
January 17, 2006
Genentech has stopped a clinical trial of a peanut-allergy treatment over safety concerns about some reactions to the drug. A Phase II trial involving asthma drug Xolair was stopped because of hypersensitivity reactions. These adverse reactions were reported in two cases.
Genentech, which is testing Xolair as a treatment for peanut allergy, will discuss alternative plans for the trial with the FDA.